IM Cannabis Corp. Common Shares (IMCC) — 分析摘要
IM Cannabis Corp. Common Shares（IMCC）的市值为2.38百万美元，最近一年的营收同比增长了-0.5%。净利润率为-21.5%。当前市盈率为-0.3倍。
核心要点
- 营收同比变化-0.5%
- 净利润率-21.5%
- 市盈率-0.3倍
IMCC的营收增长为-0.5%，市盈率为-0.3倍。
IM Cannabis Corp. Common Shares (IMCC)
更新 — ET · 市场数据 POLYGON · 财务数据 SEC EDGAR
红旗与风险提示高风险信号
存在多项实质性红旗，在依赖任何估值输出前应先重点核查这些风险。
利息保障倍数为 -3.3x — 盈利不足以覆盖利息支出
股东权益为负，可能意味着资产负债表承压。
流动比率为 0.67x — 流动负债超过流动资产
营业利润率为 -21.2% — 经营亏损显著
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority revenue is generated from Germany, and also has its presence in Israel.
员工人数
44
Exchange
XNAS
基于 4 年财务数据的系统性竞争优势评估
此评估基于历史财务数据的量化分析，不构成投资建议。护城河评级可能随行业和竞争环境变化。
首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。
资本结构
现金流
免责声明：本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。